KU Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Location status: Recruiting
NCT Number: NCT06596083
This study aims to investigate the effects of post-exercise and pre-sleep exogenous ketosis via oral ketone ester supplementation during a 5 week simulated altitude training camp.
Interested in participating?
Request Info18 year–35 year
All sexes
Interventional
Not applicable
Leuven, Vlaams-Brabant, 3000, Belgium
Location status: Recruiting
Altitude training camps, where you train at sea level but live at altitude, have become a popular way for athletes to prepare for upcoming races or events. The main aim of such training camps is to benefit from the adaptations following prolonged hypoxic exposure (increased EPO concentrations leading to an increase in oxygen carrying capacity in the blood). Recently, ketone bodies have been shown to cause similar adaptations. Therefore, this study aims to investigate whether the combination of exogenous ketosis and an altitude training camp is more beneficial compared to an altitude training camp on its own.
Participants will follow a 5 week simulated altitude training camp where they spend 75 hours per week at altitude (2000-3000 meters), while taking ketone or placebo supplements after every training sessions and before going to sleep. During these 5 weeks, they will adhere to a prescribed training plan, consisting of 5 to 7 training sessions per week. Before, after and 1 week after the training camp, their exercise performance, EPO concentrations, hemoglobin mass and VO2max will be tested.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral supplement containing: 16.4 grams of medium chained triglycerides, 1mM or sucrose octaacetate and water
Oral supplement containing: 25 grams of pure (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate ketone monoester drink
Time frame: Day 0, Day 35, Day 42
Using the optimized CO-re-breathing method, total hemoglobin mass will be estimated
Time frame: Day 0, Day 35, Day 42
Changes in muscle capillarization are measured using immunohistochemical anlyses
Time frame: Day 0, Day 35, Day 42
maximal average power output during a 30 minute time trial, cycling efficiency test and repeated sprint test
Time frame: Day 0, Day 35, Day 42
Using ergospirometry VO2max will be measured during a graded exercise test
Time frame: Day 0, Day 35, Day 42
Measured using duplex ultrasonography
Time frame: Day 0, day1, week1, week2, week3, week4, week5, day35, day42
Serum EPO concentrations will be measured using a commercially available ELISA kit
Time frame: Day 0, day1, week 3, day35, day42
Polysomnography will be used to measure sleep architecture
Contact information is provided by the study sponsor or research team.
KU Leuven
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05048680
Aging, Behavior
La Tronche, Auvergne-Rhône-Alpes, France
View Trial DetailsNCT07671638
Behavior, Exercise
La Tronche, France
View Trial DetailsNCT07341165
Behavior, Exercise
Louvain-la-Neuve, Belgium
View Trial DetailsNCT01614119
Behavior, Brain Diseases
Grenoble, France
View Trial Details